|
61
|
222
|
3f5cB |
Structure of dax-1:lrh-1 complex |
|
99
|
270
|
3et1A |
Structure of pparalpha with 3-[5-methoxy-1-(4-methoxy-benzenesulfonyl)-1h-indol-3-yl]-propionic acid |
|
93
|
245
|
3erdA |
Human estrogen receptor alpha ligand-binding domain in complex with diethylstilbestrol and a glucocorticoid receptor interacting protein 1 nr box ii peptide |
|
98
|
272
|
3et0A |
Structure of ppargamma with 3-(5-methoxy-1h-indol-3-yl)-propionic acid |
|
102
|
272
|
3et3A |
Structure of ppargamma with 3-[5-methoxy-1-(4-methoxy-benzenesulfonyl)-1h-indol-3-yl]-propionic acid |
|
105
|
269
|
3et2A |
Structure of ppardelta with 3-[5-methoxy-1-(4-methoxy-benzenesulfonyl)-1h-indol-3-yl]-propionic acid |
|
72
|
219
|
3eybA |
Structural and functional insights into the ligand binding domain of a non-duplicated rxr from the invertebrate chordate amphioxus |
|
89
|
246
|
3ertA |
Human estrogen receptor alpha ligand-binding domain in complex with 4-hydroxytamoxifen |
|
91
|
251
|
3e7cA |
Glucocorticoid receptor lbd bound to gsk866 |
|
83
|
230
|
3e94A |
Crystal structure of rxralpha ligand binding domain in complex with tributyltin and a coactivator fragment |
|
81
|
246
|
3dt3A |
Human estrogen receptor alpha lbd with gw368 |
|
102
|
268
|
3dy6A |
Ppardelta complexed with an anthranilic acid partial agonist |
|
86
|
229
|
3dcuA |
Fxr with src1 and gsk8062 |
|
95
|
300
|
3dr1A |
Side-chain fluorine atoms of non-steroidal vitamin d3 analogs stabilize helix 12 of vitamin d receptor |
|
88
|
229
|
3dctA |
Fxr with src1 and gw4064 |
|
90
|
251
|
3d57A |
Tr variant d355r |
|
95
|
266
|
3d5fA |
Crystal structure of ppar-delta complex |
|
92
|
270
|
3cwdA |
Molecular recognition of nitro-fatty acids by ppar gamma |
|
100
|
270
|
3d6dA |
Crystal structure of the complex between ppargamma lbd and the lt175(r-enantiomer) |
|
81
|
227
|
3d24A |
Crystal structure of ligand-binding domain of estrogen-related receptor alpha (erralpha) in complex with the peroxisome proliferators-activated receptor coactivator-1alpha box3 peptide (pgc-1alpha) |
|
98
|
250
|
3d90A |
Crystal structure of the human progesterone receptor ligand-binding domain bound to levonorgestrel |
|
103
|
254
|
3cs6A |
Structure-based design of a superagonist ligand for the vitamin d nuclear receptor |
|
113
|
317
|
3ctbA |
Tethered pxr-lbd/src-1p apoprotein |
|
88
|
251
|
3cldA |
Ligand binding domain of the glucocorticoid receptor complexed with fluticazone furoate |
|
101
|
254
|
3cs4A |
Structure-based design of a superagonist ligand for the vitamin d nuclear receptor |
|
99
|
275
|
3cs8A |
Structural and biochemical basis for the binding selectivity of pparg to pgc-1a |
|
74
|
237
|
3cjwA |
Crystal structure of the human coup-tfii ligand binding domain |
|
65
|
196
|
3cqvA |
Crystal structure of reverb beta in complex with heme |
|
93
|
270
|
3cdpA |
Crystal structure of ppar-gamma lbd complexed with a partial agonist, analogue of clofibric acid |
|
96
|
270
|
3cdsA |
Crystal structure of the complex between ppar-gamma and the agonist lt248 (clofibric acid analogue) |
|
82
|
253
|
3bqdA |
Doubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazol |
|
96
|
227
|
3bejA |
Structure of human fxr in complex with mfa-1 and co-activator peptide |
|
99
|
276
|
3bc5A |
X-ray crystal structure of human ppar gamma with 2-(5-(3-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)-2-phenyl-2h-1,2,3-triazol-4-yl)acetic acid |
|
92
|
270
|
3b3kA |
Crystal structure of the complex between ppargamma and the full agonist lt175 |
|
99
|
253
|
3az1A |
Crystal structure analysis of vitamin d receptor |
|
96
|
253
|
3az2A |
Crystal structure analysis of vitamin d receptor |
|
101
|
253
|
3az3A |
Crystal structure analysis of vitamin d receptor |
|
99
|
247
|
3b65A |
Crystal structure of the androgen receptor ligand binding domain in complex with sarm s-24 |
|
99
|
247
|
3b67A |
Crystal structure of the androgen receptor ligand binding domain in complex with sarm c-23 |
|
99
|
247
|
3b68A |
Crystal structure of the androgen receptor ligand binding domain in complex with sarm s-4 |
|
100
|
274
|
3b0qA |
Human ppar gamma ligand binding domain in complex with mcc555 |
|
101
|
247
|
3b5rA |
Crystal structure of the androgen receptor ligand binding domain in complex with sarm c-31 |
|
100
|
247
|
3b66A |
Crystal structure of the androgen receptor ligand binding domain in complex with sarm s-21 |
|
101
|
272
|
3b1mA |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator cerco-a |
|
104
|
254
|
3b0tA |
Human vdr ligand binding domain in complex with maxacalcitol |
|
77
|
215
|
3b0wA |
Crystal structure of the orphan nuclear receptor ror(gamma)t ligand-binding domain in complex with digoxin |
|
100
|
255
|
3ax8A |
Crystal structure of the human vitamin d receptor ligand binding domain complexed with 15alpha-methoxy-1alpha,25-dihydroxyvitamin d3 |
|
98
|
274
|
3b0rA |
Human ppar gamma ligand binding dmain complexed with gw9662 in a covalent bonded form |
|
103
|
255
|
3aurA |
Crystal structure of the human vitamin d receptor ligand binding domain complexed with yne-diene type analog of active 14-epi-2beta-methyl-19-norvitamin d3 |
|
100
|
249
|
3aunA |
Crystal structure of the rat vitamin d receptor ligand binding domain complexed with yr335 and a synthetic peptide containing the nr2 box of drip 205 |
